Aug 31, 2018
Both low-dose and full-dose rivaroxaban had superior benefit-risk profiles for extended VTE compared with aspirin. Also today, bone biopsy diagnostics for osteomyelitis vary widely, variation in bacterial drug susceptibility are tied to the risk of TB relapse, and CTA cuts MIs in patients with stable chest...
Aug 30, 2018
Rapid declines in spirometric measures of lung function were associated with higher risks of cardiovascular disease today, risankizumab provides more effect in psoriasis that ustekinumamb, there is no link between screening and liver cancer mortality, and eosinophils are a possible marker for nonceliac gluten or wheat...
Aug 29, 2018
The worldwide cardiology community has a newly revised universal definition of myocardial infarction and it refines how to distinguish between infarction and injury. Also today, high-sensitivity cardiac troponin levels are linked to cardiovascular outcomes in patients with COPD, mindfulness training for a migraine is...
Aug 28, 2018
New results from the ASCEND trial snow that neither aspirin nor fish oil provide any net clinical benefit for primary cardiovascular prevention in patients with diabetes. Also today, rivaroxaban is no help for heart failure outcomes, VTE risk is unchanged by rivaroxaban taken after discharge, and the AAP cautions
Aug 27, 2018
Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever...